Francine K. Welty
Division of Cardiology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston
USA
Name/email consistency: high
- Preventing clinically evident coronary heart disease in the postmenopausal woman. Welty, F.K. Menopause (2004)
- Alternative hormone replacement regimens: is there a need for further clinical trials?. Welty, F.K. Curr. Opin. Lipidol. (2003)
- Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol. Welty, F.K., Stuart, E., O'Meara, M., Huddleston, J. Am. J. Cardiol. (2002)
- Cardiovascular disease and dyslipidemia in women. Welty, F.K. Arch. Intern. Med. (2001)
- Reasons for higher in-hospital mortality >24 hours after percutaneous transluminal coronary angioplasty in women compared with men. Welty, F.K., Lewis, S.M., Kowalker, W., Shubrooks, S.J. Am. J. Cardiol. (2001)
- Women and cardiovascular risk. Welty, F.K. Am. J. Cardiol. (2001)
- Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans. Welty, F.K., Lichtenstein, A.H., Barrett, P.H., Jenner, J.L., Dolnikowski, G.G., Schaefer, E.J. Arterioscler. Thromb. Vasc. Biol. (2000)
- Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Welty, F.K., Lichtenstein, A.H., Barrett, P.H., Dolnikowski, G.G., Schaefer, E.J. Arterioscler. Thromb. Vasc. Biol. (1999)